摘要
我国HBV感染者约有1亿多人,其中部分人最终可发展为肝硬化、肝癌,故寻求一种有效的抗HBV药物是非常重要的.
出处
《传染病信息》
2001年第3期116-119,共4页
Infectious Disease Information
参考文献20
-
1[1]Lai CL,Chien RN,Leung NW,et al.A one-year trail of lamivudine for chronic hepatitis B Asia Hepatitis lamivudine Study Group.N Engl J Med,1998,339:61-68
-
2[2]Dienstag JT,Schiff ER,Wright TL,et al.Lamivudine as a intial treatment for chronic hepatitis B in the United States.N Engl J Med,1999,341:1256-1263
-
3[3]Schiff ER,Karayalcin S,Grimm I,et al.A placebo controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon theraphy.[Abstract].International lamivudine investigator group.Hepatology,1998,28:388A
-
4[4]Leung N,Wu PC,Tsang S,et al.Continued histological improvement in Chinese patients with chronic hepatitis B with 2 years lamivudine[Abstract].Hepatology,1998,28:489A
-
5[5]Liaw YF,Lai CL,leung NW,et al.two years lamivudine therapy in chronic hepatitis B infection:results of a placebo controlled multicenter study in Asia.Gastroenterology,1998,114:1289-1292
-
6[6]Tassopoulos NC,Volpes R,Pastore G,et al.lamivudine therapy in patients with anti-HBe positive chronic hepatitis B:end of treatment analysis.J Hepatol,1998,28(suppl 1):43-45
-
7[7]Chien RN,Liaw YF,Atkins M,et al.Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B.Hepatology,1999,30(3):770-774
-
8[8]Lai CL,Ching CK,Tung AK,et al.Lamivudine is effective in suppressing hepatitis B virus DNA in chinese hepatitis B surface antigen carrier.Hepatology,1997,25(1):241-244
-
9[9]Lau DT; Doo E,Park Y,et al.lamivudine for chronic delta hepatitis.Hepatology,1999,30(2):546-549
-
10[10]Buti M,Cotrina M,Cruz de castro E,et al.One year treatment with lamivudine in different hepatitis B virus related hepatic diseases.Gastroenterol·Hepatol,1999,22(3):117-121
同被引文献64
-
1郭亚兵 喻新民 等.拉米夫定停药后慢性乙型肝炎病情加重3例报道[J].中华肝脏病杂志,2000,8(6):360-360.
-
2沈春明.病毒性肝炎治疗问题[J].传染病信息,2001,14(7):14-19.
-
3[2]Dienstag JT,Schiff ER,Wright TL,et al. Lamivudine as a intial treatment for chronic hepatitis B in the vnited States [J]. N Engl J Med,1999,238:1231~1239
-
4[3]Schiff ER, Karayalcin S, Grimm I, et al. A placebo controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon theraphy. [Abstract]. International lamivudine investigator group[J]. Hepatology, 1999,29: 237
-
5[4]Leung N, Wu PC, Tsang S, et al. Continued histological inprovement in Chinese patients with chronic hepatitis B with 2 year lamivudine [Abstract][J]. Hepatology, 1998,28:476
-
6[5]Liaw YF, Lai CL, leung NW, et al. two years lamivudine therapy in chronic hepatitis B infection. Results of a placebo controlled multicenter study in Asia[J]. Gastroenterology,1998,114:1276~1285
-
7[6]Tassopoulos NC,Volpes R, Pastore G, et al. Lamivudine therapy in patients with anti - Hbe positive chronic hepatitis B: end of treatment analsis[J]. J Hepatol, 1998, 28(suppll):48~51
-
8陆海英,王勤环,曾争,等.拉米夫定治疗慢性乙型肝炎重叠HDV感染的疗效观察[J].传染病信息,2000,13(6):10-102.
-
9[9]Buti M, Cotrina M, Cruz de casteo E, et al. One year treatment with lamivudine in diffirint hepatitis B virus related hepatic diseases[J]. Gastroenterol Hepatol, 2000,23(2):112~116
-
10[10]VAILLENEUVE JP, Condreay LD,Willems B,et al. Lamivudine treatment for decompensated cirrhosis reaulting from chronic hepatitis B[J]. Hepatology, 2000,31(3):107~110
引证文献7
-
1马洪波,刘芳,郑风,晁军平.拉米夫定联合胸腺肽治疗慢性乙型肝炎40例[J].菏泽医学专科学校学报,2004,16(3):20-22.
-
2杨泉海.乙型肝炎病毒对拉米夫定耐药性研究近况[J].浙江中西医结合杂志,2002,12(11):724-725.
-
3杨泉海,王咏梅.拉米夫定治疗慢性乙肝的疗效评价[J].首都医药,2003,10(22):32-34. 被引量:1
-
4杨泉海,王咏梅.乙型肝炎病毒变异与拉米夫定治疗的研究近况[J].中国医院药学杂志,2004,24(3):175-176.
-
5曹茜.拉米夫定抗乙型肝炎病毒治疗中耐药研究综述[J].天津药学,2004,16(2):71-73. 被引量:5
-
6黄君杏.拉米夫定治疗慢性HBV感染的研究近况[J].医学文选,2004,23(2):215-218.
-
7吴守幸,白冰.慢性HBV感染抗病毒治疗现状和进展[J].新疆医学,2004,34(2):120-121.
二级引证文献6
-
1杨泉海,王霞.拉米夫定致乙型肝炎病毒变异及其临床对策[J].中国医院用药评价与分析,2004,4(3):183-185. 被引量:5
-
2潘晓华,储峰.拉米夫定治疗慢性乙型肝炎患者138例临床观察[J].世界感染杂志,2009,9(2):107-109. 被引量:4
-
3李建国,柴艳云,刘密霞,秦惠清,王先英.拉米夫定治疗慢性乙型肝炎患者3年疗效观察[J].实用肝脏病杂志,2010,13(2):97-99. 被引量:3
-
4宋薇,张义强.阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎疗效观察[J].中国现代医生,2010,48(11):52-52. 被引量:3
-
5丁宁.阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎临床观察[J].中国实用医药,2011,6(5):152-153.
-
6朱培福.拉米夫定治疗慢性乙型肝炎220例临床观察[J].中国医疗前沿,2007,2(21):24-25. 被引量:1
-
1王宇明.重型肝炎的内科治疗[J].中华肝脏病杂志,2001,9(4):243-245. 被引量:17
-
2佘会元,黄春红,沈黎辉,沈文娟,况成宝,黄钟鸣,赵旭,孙莉萍.替比夫定联合双虎清肝颗粒治疗HBeAg阳性慢性乙型肝炎[J].中华传染病杂志,2010,28(10):627-630. 被引量:1
-
3冯金辉,黄维亮,刘凤娥.阿德福韦酯治疗慢性乙型肝炎的疗效观察[J].中国实用医药,2010,5(10):29-31. 被引量:1
-
4赵长青.慢性乙型肝炎和肝硬化的“双抗”疗法[J].肝博士,2016,0(6):39-39.
-
5张春生.动态心电图监测变异型心绞痛的临床价值分析[J].当代医学,2012,18(2):95-96. 被引量:6
-
6严小宏,杨梅英,温维勤.2型糖尿病合并阻塞性睡眠呼吸暂停综合征2例治疗体会[J].内科急危重症杂志,2011,17(5):319-320. 被引量:3
-
7张自正.硝酸甘油合冠心宁注射液治疗不稳定型心绞痛[J].浙江中西医结合杂志,2004,14(3):156-156.
-
8朱宇波.苯磺酸左旋氨氯地平片治疗原发性高血压的临床疗效观察[J].临床合理用药杂志,2014,7(33):32-33. 被引量:4
-
9魏欣,张旭东,王莉.拉米夫定联合用药治疗慢性乙型肝炎的应用进展[J].中国药房,2008,19(17):1351-1353. 被引量:3
-
10司银梅,向楠.以便秘为主要临床表现的桥本甲状腺炎1例分析[J].中西医结合研究,2012,4(2):112-112. 被引量:2